Norges Bank’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ORTX
DM
RCM
CI
DCM
VMI
Norges Bank's ORTX Position: Q1 2019 in Review
Norges Bank sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2019, closing a stake of 4,000 shares — an estimated $629K sold.
Norges Bank first reported a position in ORTX in Q4 2018 and held it in 1 quarter. The position peaked at $629K in Q4 2018. 43 funds tracked by Wall St. Rank hold ORTX as of Q1 2019.
- Norges Bank reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
- Norges Bank sold 4,000 Orchard Therapeutics plc American Depositary Shares shares in Q1 2019, an estimated $629K.
- Norges Bank first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 1 quarter.
- Norges Bank's Orchard Therapeutics plc American Depositary Shares position peaked at $629K in Q4 2018.
- 43 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2019.
Based on Norges Bank's 13F filing for Q1 2019, filed 9 May 2019.